David Maxwell Hunter Chascsa

8PUBLICATIONS
30CO-AUTHORS
Medical biochemistry - lipidsHaematological tumoursMetabolic medicineCardiology (incl. cardiovascular diseases)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 26, 2026
Aspirin Use and Liver-Related Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis.

|May 06, 2025
Long-Term Outcomes of Fenofibrate for Treatment of Ischemic Cholangiopathy in Donation After Circulatory Death Liver Transplantation.

Channa R Jayasekera, Michele Barnhill, David M H Chascsa

|Jul 27, 2024
Exploring Varied Treatment Strategies for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Amani Elshaer, David M H Chascsa, Blanca C Lizaola-Mayo

|Jan 12, 2023
Long-term clinical outcomes of patients with COVID-19 and chronic liver disease: US multicenter COLD study.

Elizabeth S Aby, Ghady Moafa, Nyan Latt

|May 06, 2022
Special Considerations in the Management of HIV and Viral Hepatitis Coinfections in Liver Transplantation.

Josiah D McCain, David M Chascsa

|Jun 18, 2020
Update on Emerging Treatment Options for Primary Biliary Cholangitis.

Maria T Aguilar, David M Chascsa

Pageof 2

Frequent Collaborators

2 joint publications

Hugo E Vargas

2 joint publications

Bashar A Aqel

1 joint publications

A P Keaveny

1 joint publications

Elizabeth S Aby